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ABSTRACT 
 
The purpose of this retrospective study was to review the patient records with 
regard to demographics, clinical presentation, laboratory tests, histology, 
management and outcome of patients presenting at Chris Hani Baragwanath and 
Charlotte Maxeke Johannesburg Academic Hospitals with pituitary adenomas 
over a ten year period from 1999 to 2008. 
 
Methods:  The patient records accessed included discharge summaries, 
admission files, laboratory results, imaging films, ophthalmology records and 
histology results. 
The information gathered was analyzed in terms of the above mentioned 
parameters.  
 
Results: There was a slight female preponderance at 55% vs 45% males, 
with a mean age of 46 years.  89% of the study population was of a Black race, 
reflecting the actual demographic pattern of the hospital population rather than 
the tumour prevalence in Blacks. 
 
Visual disturbance (94%) and headaches (75%) were very common and reflected 
the late presentation of our patients.  Features of hypopituitarism and 
hyperprolactinaemia were the commonest of hormone imbalances at 33% and 
39% respectively.  80% of the total study population was treated by 
transphenoidal surgery.  The remainder was mainly prolactinomas treated with 
oral dopamine agonists and those who refused surgery.  2% required transcranial 
approach while 13% received further radiation therapy. 
 
Outcome was good with regard to improvement or resolution of headaches at 
65%, while improvement in visual acuity and field defects were less satisfactory, 
with 51% showing improvement, and 44% remaining the same post operatively.  
This underlies the concern regarding late presentation of our patients with 
irreversible visual impairment. 
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100% of prolactinomas showed improvement or normalization of the prolactin 
levels with bromocriptine or carbegoline, however, of those who presented with 
hypopituitarism 43% required post operative hormone replacement in the form of 
cortisol acetate or prednisone and thyroxin. 
 
Conclusion: Our patient demographics are similar to those published elsewhere, 
however, of great concern is the late presentation with irreversible visual 
impairment and hormonal imbalance.  Government and community education, in 
a multidisciplinary approach is required to improve our situation. 
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PATIENT NAME: ________________________________________ 
 
HOSPITAL NUMBER:  ___________________________________ 
 
AGE: _______  SEX: ___________  RACE:  _____________________ 
 
CLINICAL PRESENTATION: 
 
1. Vision 
2. Headache 
3. Hormonal imbalance 
 
RADIOLOGY: 
 
 Hardy Type:  
 
LAB RESULTS: 
1. Prolactin 
2. Growth Hormone 
3. Cortisol 
4. Thyroid Function Test 
 
HISTOLOGY: 
 
MANAGEMENT: 
 
1. Surgical 
a) Transphenoidal 
b) Transcranial 
 
2. Medical  
 
____________________________________________________________ 
 
3. Surgical and Medical 
 
  ____________________________________________________________ 
 
4. Radiation 
   
  ____________________________________________________________ 
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COMPILICATIONS: 
 
1. Bleeding 
2. Diabetes Insipidus 
3. Cerebral Salt Wasting  
4. Syndrome of Inappropriate Anti Diuretic Hormone 
 
OUTCOME: 
 
1. Headache 
2. Vision 
3. Hormones 
 
